Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy

NCT00474838 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Pancreatic Beta Cell Function
Glucotoxicity

Interventions

DRUG: intensive insulin group
DRUG: Oral AntiDiabetic Drug (glimepiride and metformin)

Sponsor

Kyunghee University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]